Cargando…
Safety of a 3-Step "Catch-Up Protocol” in Re-establishing Maintenance Dose Subcutaneous Immunotherapy (SCIT) Post Covid-19 Lockdown During Allergy Season.
Autores principales: | Ogeer, Ijaz, Wardha, Wardha., Bhatt, Vaidehi, Wu, Vince, Hosein, Saajida, Seto, Tyler, Gyaltsen, Tenzin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849496/ http://dx.doi.org/10.1016/j.jaci.2020.12.048 |
Ejemplares similares
-
Covid impact in allergy: patients' perceptions of "virtual” consultations and preferences for the future.
por: Wu, Vince, et al.
Publicado: (2021) -
Assisting Front Liners: The Benefits Of Allergy Consultation On The Challenges To Covid Vaccination
por: Wu, Vince, et al.
Publicado: (2022) -
A COVID-19 vaccine success? patients perception of Covid vaccination program
por: Wardha, Wardha., et al.
Publicado: (2021) -
Uterine Anaphylaxis Due to Subcutaneous Immunotherapy (SCIT) for Inhalant Allergens: A Case Series
por: Ganguli, Malika P, et al.
Publicado: (2023) -
De novo sensitization during subcutaneous allergen specific immunotherapy - an analysis of 51 cases of SCIT and 33 symptomatically treated controls
por: Gellrich, Donata, et al.
Publicado: (2020)